Skip to main content

HeartBeam, Inc.

corporate_fare Company Profile

HeartBeam, Inc.

BEAT·NASDAQ·Industrial Applications And Services·CIK 0001779372

HeartBeam is a medical technology company that develops innovative, higher resolution ambulatory cardiac monitoring solutions. The company's proprietary and patented technology platform collects the heart's electrical activity from three dimensions and synthesizes a 12-Lead (12L) Electrocardiogram (ECG) from these signals. HeartBeam aims to enable the detection and monitoring of cardiac disease outside of a healthcare facility. The company believes its products and services will benefit patients, healthcare providers, and healthcare payers, and address the rapidly growing field of ambulatory cardiac monitoring. HeartBeam's long-term vision includes playing a central role in high-risk Coronary Artery Disease (CAD) monitoring, supported by initial feasibility studies demonstrating comparable performance of the HeartBeam System and the standard 12L ECG in ischemia detection. The HeartBeam System is the company's initial product and service offering. It is the first U.S. Food and Drug Administration (FDA) cleared cable-free, ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment. The HeartBeam System includes a credit card sized 3D ECG recording device, a patient application, a physician portal, and cloud-based algorithms. Its patented cable-free technology captures the heart's electrical signals in three non-coplanar dimensions and synthesizes them into a 12L ECG display using a personalized transformation matrix.

HeartBeam, Inc. (NASDAQ:BEAT) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 35 items for BEAT at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • HeartBeam Reiterates Going Concern, Secures $11.5M in Dilutive Offering Post-Q1
  • HeartBeam Launches Pilot Study for First On-Demand 12-Lead ECG Patch to Detect Ischemia
  • HeartBeam Expands U.S. Commercial Footprint into Four Key Markets
  • Director Willem Elfrink Buys $150K in HeartBeam Public Offering Amidst Insider Cluster
  • Director Richard Ferrari Buys $50K in HeartBeam Public Offering Amidst Going Concern

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$21.02M
Diluted EPS
-$0.62
Op. Cash Flow
-$13.99M
Free Cash Flow
-$14.59M
Operating Income
-$21.14M
Cash & Equivalents
$4.38M
Debt / Equity
0.00×
Shares Outstanding
26.96M sh
Source: 10-K · filed 2026-03-12 · accession 0001193125-26-104080
$0.2936 +6.73% today
52-week range · as of 2026-11-12 $0.2936 – $4
Market cap
$17.42M
Volume
659.8K (0.6× avg)
3-mo avg 1.2M
Live data · 2026-11-21 17:18 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed BEAT - Filings & News (Page 2)

BEAT
May 13, 2026, 4:02 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.05
Real-time Price: $0.293604 info
Change: -$0.756396 (-72%) info
Market Cap: $17.417M info
BEAT
May 11, 2026, 9:13 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $0.8919
Real-time Price: $0.293604 info
Change: -$0.598296 (-67%) info
Market Cap: $17.417M info
BEAT
May 07, 2026, 8:32 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.8924
Real-time Price: $0.293604 info
Change: -$0.598796 (-67%) info
Market Cap: $17.417M info
BEAT
Apr 16, 2026, 8:48 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $0.8493
Real-time Price: $0.293604 info
Change: -$0.555696 (-65%) info
Market Cap: $17.417M info
BEAT
Apr 16, 2026, 8:47 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $0.8493
Real-time Price: $0.293604 info
Change: -$0.555696 (-65%) info
Market Cap: $17.417M info
BEAT
Apr 16, 2026, 8:46 PM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $0.8493
Real-time Price: $0.293604 info
Change: -$0.555696 (-65%) info
Market Cap: $17.417M info
BEAT
Apr 16, 2026, 4:48 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.8498
Real-time Price: $0.293604 info
Change: -$0.556196 (-65%) info
Market Cap: $17.417M info
BEAT
Apr 15, 2026, 9:55 PM EDT
Filing Type: 424B5
Importance Score:
9
Price at Filing: $0.8901
Real-time Price: $0.293604 info
Change: -$0.596496 (-67%) info
Market Cap: $17.417M info
BEAT
Apr 14, 2026, 10:11 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $1.06
Real-time Price: $0.293604 info
Change: -$0.766396 (-72%) info
Market Cap: $17.417M info
BEAT
Apr 14, 2026, 4:22 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $0.970
Real-time Price: $0.293604 info
Change: -$0.676396 (-70%) info
Market Cap: $17.417M info
BEAT
Apr 14, 2026, 4:10 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $0.996
Real-time Price: $0.293604 info
Change: -$0.702396 (-71%) info
Market Cap: $17.417M info
BEAT
Mar 25, 2026, 12:46 PM EDT
Source: FinanceWire
Importance Score:
7
Price at Filing: $1.19
Real-time Price: $0.293604 info
Change: -$0.892696 (-75%) info
Market Cap: $17.417M info
BEAT
Mar 13, 2026, 12:41 PM EDT
Source: FinanceWire
Importance Score:
7
Price at Filing: $1.37
Real-time Price: $0.293604 info
Change: -$1.08 (-79%) info
Market Cap: $17.417M info
BEAT
Mar 12, 2026, 4:02 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $1.44
Real-time Price: $0.293604 info
Change: -$1.15 (-80%) info
Market Cap: $17.417M info
BEAT
Feb 09, 2026, 4:05 PM EST
Filing Type: S-3
Importance Score:
9
Price at Filing: $1.43
Real-time Price: $0.293604 info
Change: -$1.14 (-79%) info
Market Cap: $17.417M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets